SART3-derived peptides useful for cancer vaccine therapy for HLA-A3 supertype allele positive prostate cancer patients

摘要

The present invention provides SART3-derived peptides that can bind to HLA-A3 supertype allele molecules and are recognized by cellular immunity. The present invention is particularly useful for the treatment of prostate cancer patients who are negative for HLA-A2 or HLA-A24 molecules, for which many cancer vaccine candidate peptides have been identified so far.